Rate My Professor Robert Baxter

A distinguished cancer researcher, Baxter possesses primary expertise in biochemistry, cell biology, and proteomics, underpinned by a background in endocrinology and metabolic research. His seminal contributions focus on insulin-like growth factor binding proteins (IGFBPs) and their signaling pathways, particularly in relation to tumor growth and breast cancer progression. With over 300 peer-reviewed publications, his work has garnered more than 35,000 citations and an h-index of 96 on Google Scholar. Key publications include 'Insulin-like growth factor-binding protein from human plasma. Purification and characterization' (Journal of Biological Chemistry, 1986), 'Cellular actions of the insulin-like growth factor binding proteins' (Endocrine Reviews, 2002), 'Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities' (American Journal of Physiology-Endocrinology and Metabolism, 2000), and 'Signaling Pathways of the Insulin-like Growth Factor Binding Proteins' (Endocrine Reviews, 2023). Baxter's research has significantly influenced understandings of IGFBP functions in cancer and metabolic diseases, contributing to advancements in targeted therapies. In recognition of his impact, he was awarded the Member (AM) of the Order of Australia in 2020 for significant service to medical research. He has secured funding such as the Cancer Institute NSW grant for 'ZOOMing in on new cancer therapies: Real-time quantitative live cell imaging for cancer research and drug discovery' in 2017.